Connection template - EMA ESTRI Gateway using an AS2 compatible product

Connecting to the Agency ESTRI Gateway using an AS2 compatible product

EudraVigilance - EVWEB user manual

EudraVigilance support guide

Opinion/decision on a Paediatric investigation plan (PIP): Xofluza, Baloxavir marboxil, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0098/2023

Vaccine Monitoring Platform: List of EMA-funded studies

Multi-stakeholder webinar on the HMA-EMA Catalogues of real-world data sources and studies, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 4 March 2024, 10:00 (CET) to 4 March 2024, 12:00 (CET)

Opinion/decision on a Paediatric investigation plan (PIP): Evkeeza, Evinacumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism, PIP number: P/0087/2023

Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications - 2024-2025

Meeting Report of the second Listen and Learn Focus Group (LLFG) meeting of the Quality Innovation Group (QIG)